Combination therapy for the treatment of CD19+ b-cell malignancies symptoms comprising an anti-CD19 maytansinoid immunoconjugate and rituximab

PK201200504A0Undetermined Publication Date: 2012-09-05SANOFI SA(FR)
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
SANOFI SA(FR)
Filing Date
2012-07-27
Publication Date
2012-09-05
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.